What is it about?
Slight elevation in ketone levels on well days predicts future ketoacidosis events in T1D in those using SGLT inhibitors (as it did in non-users), offering a strategy to decrease DKA risk.
Featured Image
Read the Original
This page is a summary of: Capillary Ketone Level and Future Ketoacidosis Risk in Patients With Type 1 Diabetes Using Sodium–Glucose Cotransporter Inhibitors, Diabetes Care, April 2025, American Diabetes Association,
DOI: 10.2337/dc25-0125.
You can read the full text:
Contributors
Be the first to contribute to this page
